COVID-19 and the UK Biobank-Opportunities and Challenges for Research and Collaboration With Other Large Population Studies

Mohammed Y Khanji; Nay Aung; C Anwar A Chahal; Steffen E Petersen

doi:10.3389/fcvm.2020.00156

COVID-19 and the UK Biobank-Opportunities and Challenges for Research and Collaboration With Other Large Population Studies

Front Cardiovasc Med. 2020 Aug 27:7:156. doi: 10.3389/fcvm.2020.00156. eCollection 2020.

Authors

Mohammed Y Khanji^{1

2}, Nay Aung^{1

2}, C Anwar A Chahal^{2

3

4}, Steffen E Petersen^{1

2}

Affiliations

¹ Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
² NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
³ Department of Cardiology, University of Pennsylvania, Philadelphia, PA, United States.
⁴ Department of Cardiovascular Diseases, Mayo Clinic, Rochester, NY, United States.

Abstract

Large population studies such as the UK Biobank provide great opportunities for understanding the pathophysiology, health impact and prognostic factors associated with COVID-19, a condition that has had significant impact on almost everyone around the world. We highlight the vast opportunities, challenges and limitations for research and collaboration from the UK Biobank and other large population studies in helping us better understand and manage both current and potential future pandemics.

Keywords: COVID-19; UK Biobank; epidemiology; population studies; precision medicine.

Abstract

Grants and funding